Activity of an anti-inflammatory drug against cryptosporidiosis in neonatal lambs

Veterinary Parasitology

Volumn 155, Issue 3-4, 2008, Pages 308-313

  Castro Hermida, José Antonio ^a   García Presedo, Ignacio ^a   González Warleta, Marta ^a   Mezo, Mercedes ^a   Fenoy, Soledad ^b   Rueda, Cristina ^b   del Águila, Carmen ^b  

^a Centro de Investigacions Agrarias de Mabegondo   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Anti inflammatory; Bobel 24; Control methods protozoa; Cryptosporidium parvum; Lamb protozoa

Indexed keywords

ANTIINFLAMMATORY AGENT; BOBEL 24;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; FECES ANALYSIS; FEMALE; INFECTION PREVENTION; INOCULATION; LAMB; LOW DRUG DOSE; MALE; NEWBORN; NONHUMAN; OOCYST; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; ANTIPARASITIC AGENTS; BIRTH WEIGHT; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; FECES; FEMALE; MALE; PARASITE EGG COUNT; PHENOLS; SHEEP; SHEEP DISEASES; WEIGHT GAIN;

ANIMALIA; CRYPTOSPORIDIUM PARVUM; OVIS ARIES; PROTOZOA;

EID: 47149107920     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2008.05.012     Document Type: Article

References (30)

1. Argenzio R.A., Liacos J.A., Levy M.L., Meuten D.J., Lecce J.G., and Powell D.W. Villous atrophy crypt hyperplasia cellular infiltration and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology 98 (1990) 1129-1140
2. Argenzio R.A., Lecce J., and Powell D.W. Prostanoids inhibit intestinal NaCl absorption in experimental porcine cryptosporidiosis. Gastroenterology 104 (1993) 440-447
3. Argenzio R.A., Armstrong M.U., and Rhoads J.M. Role of the enteric nervous system in piglet cryptosporidiosis. J. Pharmacol. Exp. Ther. 279 (1996) 1109-1115
4. Castro-Hermida J.A., Quílez-Cinca J., López-Bernad F., Sánchez-Acedo C., Freire Santos F., and Ares-Mazás M.E. Treatment with β-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions. Int. J. Parasitol. 31 (2001) 1134-1137
5. Castro-Hermida J.A., Gónzalez-Losada Y., Freire Santos F., González-Warleta M., Mezo-Menéndez M., and Ares-Mazás M.E. Efficacy of β-cyclodextrin against experimental cryptosporidiosis in neonatal lambs. J. Parasitol. 88 (2002) 185-187
6. Castro-Hermida J.A., Pors I., Otero-Espinar F., Luzardo-Alvarez A., Ares-Mazás E., and Chartier C. Efficacy of alpha-cyclodextrin against experimental cryptosporidiosis in neonatal goats. Vet. Parasitol. 120 (2004) 35-41
7. Castro-Hermida J.A., Pors I., Méndez-Hermida F., Ares-Mazás E., and Chartier C. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts. Vet. J. 171 (2006) 340-345
8. Chartier C., Mallereau M.P., and Naciri M. Prophylaxis using paromomycin of natural cryptosporidial infection in neonatal kids. Prev. Vet. Med. 25 (1996) 357-361
9. Chartier C., Mallereau M.P., and Lenfant D. Efficacité du lactate d'halofuginone dans la prévention de la cryptosporidiose chez le chevreau nouveau-né. Rev. Méd. Vét. 150 (1999) 341-346
10. Chen X.M., and LaRusso N. Human intestinal and biliary cryptosporidiosis. World J. Gastroenterol. 5 (1999) 424-429
11. Chen X.M., and LaRusso N. Mechanism of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology 118 (2000) 368-379
12. Cole J., Blikslager A., Hunt E., Gookin J., and Argenzio R. Cyclooxygenase blockade and exogenous glutamine enhance sodium absorption in infected bovine ileum. Am. J. Physiol. Gastrointest. Liver Physiol. 284 (2003) G516-G524
13. de Graaf D.C., Vanopdenbosch E., Ortega-Mora L.M., Abbassi H., and Peeters J.E. A review of the importance of cryptosporidiosis in farm animals. Int. J. Parasitol. 29 (1999) 1269-1287
14. Fayer R., and Ungar B.L.P. Cryptosporidium spp. and cryptosporidiosis. Microbiol. Rev. 50 (1986) 458-483
15. García-Capdevila L., López-Calull C., Pompermayer S., Arroyo C., Molins-Pujol A.M., and Bonal J. High-performance liquid chromatography analysis of Bobel-24 in biological samples for pharmacokinetic metabolic and tissue distribution studies. J. Chromatogr. B 708 (1998) 169-175
16. Heine J. Eine einfache Nachweismethode für Kryptosporidien in Kot. Zentralbl. Veterinärmed. Reihe B 29 (1982) 324-327
17. Korich D.G., Mead J.R., Madore M.S., Sinclair N.A., and Sterling C.R. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocysts viability. Appl. Environ. Microbiol. 56 (1990) 1423-1428
18. 2α production. Infect. Immun. 66 (1998) 1787-1790
19. LeChevalier M.W., Di Giovanni G.D., Clancy J.L., Bukhari Z., Bukhari S., Rosen J.S., Sobrinho J., and Frey M.M. Comparison of Method 1623 and cell culture-PCR for detection of Cryptosporidium spp. in source waters. Appl. Environ. Microbiol. 69 (2003) 971-979
20. López-Belmonte J., and Norton J.A. Protection against chronic colonic inflammation by Bobel-246: effect on cellular infiltration 5-lipoxygenase and inducible nitric oxide synthase. Inflamm. Res. 46 (1997) S256
21. López-Belmonte J., and Norton J.A. Protection against colonic injury by 5-lipoxygenase inhibitors: a comparative study. Med. Inflamm. 8 (1999) S154
22. Lorenzo M.J., Ares-Mazás M.E., Villacorta I., and Duran D. Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts. J. Parasitol. 79 (1993) 67-70
23. Mancassola R., Repérant J.M., Naciri M., and Chartier C. Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study. Antimicrob. Agents Chemother. 39 (1995) 75-78
24. Naciri, M., Yvoré, P., Leieux, D., October 1984. Cryptosporidiose expérimentale du chévreau. Influence de la prise du colostrum. Essais de traitements. In: Yvoré, P., Perrin, G. (Eds.), Les maladies de la chévre. INRA Publications, Les colloques de I'INRA, no. 28, Niort, France. INRA, Paris, pp. 465-471.
25. Parreño M., Vaqué J.P., Casanova I., Frade P., Céspedes M.V., Pavón M.A., Molíns A., Camacho M., Vila L., Nomdedeu J.F., Mangues R., and León J. Novel triiodophenol derivatives induce caspase-independent mitochondrial cell death in leukemia cells inhibited by Myc. Mol. Cancer Ther. 5 (2006) 1166-1175
26. Rueda C., Fenoy S., Simón F., and del Águila C. Bobel-24 activity against Cryptosporidium parvum in cell culture and in a SCID mouse model. Antimicrob. Agents Chemother. 52 (2008) 1150-1152
27. Trocóniz I.F., Zsolt I., Garrido M.J., Valle M., Antonijoan R.M., and Barbanoj M.J. Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B4 synthesis inhibitor. Pharm. Res. 23 (2006) 1533-1542
28. Viu M., Quílez J., Sánchez-Acedo C., Del Cacho E., and López-Bernard F. Field trial on the therapeutic efficacy of paromomycin on natural Cryptosporidium parvum infections in lambs. Vet. Parasitol. 90 (2000) 163-170
29. Xiao L., Morgan U.M., Limor J., Escalante A., Arrowood M., Shulaw W., Thompson R.C.A., Fayer R., and Lal A.A. Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl. Environ. Microbiol. 65 (1999) 3386-3391
30. Yvoré, P., Esnault, A., Naciri, M., Leclerc, C., Bind, J.L., Contrepois, M., Levieux, D., Laporte, J., October 1984. Enquète épidémiologique sur les diarrhées néonatales des chevreaux dans les élevages de Touraine. In: Yvoré, P., Perrin, G. (Eds.), Les maladies de la chévre. INRA Publications, Les colloques de I'INRA, no. 28, Niort, France. INRA, Paris, pp. 437-442.